Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea

Chest

Volumn 111, Issue 6, 1997, Pages 1500-1504

  Olopade, Christopher O ^a,b   Christon, James A ^a   Zakkar, Mohamed ^a   Hua, Chi Wei ^a   Swedler, William I ^a   Scheff, Peter A ^a   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Airway; Inflammation; Lipid peroxidation; Nose; Oxidants

Indexed keywords

NITROUS OXIDE; PENTANE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SLEEP; SLEEP APNEA SYNDROME; SMOKING;

EID: 0031010888     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1500     Document Type: Article

References (40)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-35
2. Hung J, Whiford EG, Parsons RW, et al. Association of sleep apnea with myocardial infarction in men. Lancet 1990; 336:261-64
3. Schmidt-Nowara WW, Coultas DB, Wiggins C, et al. Snoring in a Hispanic American population: risk factors for and association with hypertension and other morbidity. Arch Intern Med 1990; 150:597-601
4. Koskenvuo M, Kaprio J, Partinen M, et al. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985; 1:893-96
5. Rubinstein I, Slutsky AS, Zamel N, et al. Paradoxical glottic narrowing in patients with severe obstructive apnea. J Clin Invest 1988; 81:1051-55
6. Issa FG, Sullivan CK. Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 1984; 57:520-27
7. Issa FG, Sullivan CE. Upper airway closing pressures in snorers. J Appl Physiol 1984; 57:528-35
8. Morrison DL, Laimois SH, Isono S. Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea. Am Hev Respir Dis 1993; 148:606-11
9. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126:625-28
10. Leznoff A, Haight JS, Hoffstein V. Reversible obstructive sleep apnea caused by occupational exposure to guar gum dust. Am Rev Respir Dis 1986; 133:935-36
11. Zwillich CW, Pickett C. Hanson FN, et al. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis 1981; 124:158-60
12. Wynne JW. Obstruction of the nose and breathing during sleep. Chest 1982; 82:657-58
13. Rubinstein I. Nasal inflammation is present in patients with obstructive sleep apnea. Laryngoscope 1995; 105:175-77
14. Sekosan M. Zakkar M, Wenig B, et al. Inflammation is present in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 1996; 106:1018-20
15. Zakkar M, Sekosan M, Wenig B, et al. Decrease in immunoreactive neutral endopeptidase in uvula mucosa epithelium of patients with obstructive sleep apnea. Laryngoscope (in press)
16. Saul S. Kimmelman CP, LiVolsi VA, et al. Histopathology of sleep apnea. Trans Am Laryngol Assoc 1988; 109:222-25
17. Zarling EJ, Clapper M. Technique for gas chromatographic measurements of volatile alkanes from single-breath samples. Clin Chem 1987; 33:140-41
18. Zarling EJ, Mobarhan S, Bowen P, et al. Oral diet does not alter pulmonary pentane or ethane excretion in healthy subjects. J Am Coll Nutr 1993; 11:349-52
19. Olopade CO, Zakkar M, Swedler WI, et al. Exhaled pentane levels in acute asthma. Chest 1997; 111:862-65
20. Kokoszka J. Nelson RL, Swedler WI, et al. Determination of inflammatory bowel disease activity by breath pentane analysis. Dis Colon Rectum 1993; 36:597-601
21. Borland C, Cox Y, Higenbottam T. Measurement of exhaled nitric oxide in man. Thorax 1993; 48:1160-62
22. Gaston B, Drazen JM, Wohl MB, et al. Expired nitric oxide concentrations are elevated in patients with reactive airways diseuse [abstract]. Endothelium 1993; 1:343
23. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric-oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-35
24. Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343:146-47
25. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152:800-03
26. Rechtscchaffen A, Kales A. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. US Department of Health, Education and Welfare publication No. (NIH) 204, Bethesda, Md: National Institute of Health, 1968
27. Hoffstein V, Rubinstein I, Mateika S. Determinants of blood pressure in snorers. Lancet 1988; 2:992-94
28. Robbins RA, Floreani AA, Von Essen S, et al. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 1996; 153:1631-35
29. Horton JW, Walker PB. Oxygen radicals, lipid peroxidation, and permeability changes alter intestinal ischemia and reperfusion. J Appl Physiol 1993; 74:1515-20
30. Morita S, Snider MT, Inada Y. Increased N-pentane excretion in humans: a consequence of pulmonary oxygen exposure. Anesthesiology 1986; 64:730-33
31. Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994; 17:127-60
32. Weitz ZW, Birnbaum AJ, Sobotka PA, et al. High breath pentane concentrations during acute myocardial infarction. Lancet 1991; 337:933-35
33. Kneepkens CMF, Ferreira C, Lepage G. et al. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin Invest Med 1992; 15:163-86
34. Kneepkens CMF, Ferreira C, Lepage C, et al. Hydrocarbon breath test in cystic fibrosis: evidence for increased lipid peroxidation [abstract]. J Pediatr Gastroenterol Nutr 1992; 15:344A
35. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-70
36. Lundberg JON, Farkas-Szallasi T, Weitzberg E. et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1:370-73
37. Kharitinov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis [abstract]. Am J Respir Crit Care Med 1994; 149:A198
38. Schilling J, Holzer P, Gugenbach D, et al. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur Respir J 1994; 7:467-71
39. Kanazawa H, Shoji S, Hirata K, et al. Role of endogenous nitric oxide in airflow obstruction in smokers. Chest 1996; 110:927-29
40. Dillon WC, Hampl V, Shultz PJ, et al. Origins of breath nitric oxide in humans. Chest 1996; 110:930-38